重组Anti-Cytokeratin 8 (phospho S431)抗体[EP1630]
Anti-Cytokeratin 8 (phospho S431) antibody [EP1630]
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(3 Publications)
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (AB109452)
Immunocytochemistry analysis of HeLa (human cervix adenocarcinoma epithelial cell) labeling Cytokeratin 8 with purified ab109452 at 1/500 dilution. Cells were fixed with 4% Paraformaldehyde and permeabilised with 0.1% tritonX-100. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/1000 (2 µg/ml) was used as the secondary antibody. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.26 µg/ml) was used as counterstain. Nuclei were stained blue with DAPI.
Negative control : PBS instead of the primary antibody.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (AB109452)
ab109452 at 1/100 dilution staining Cytokeratin 8 in Human ductal breast carcinoma by Immunohistochemistry, Paraffin-embedded tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (AB109452)
ab109452 at 1/100 dilution staining Cytokeratin 8 in Human stomach adenocarcinoma by Immunohistochemistry, Paraffin-embedded tissue.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IP
Lab
Immunoprecipitation - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (AB109452)
Purified ab109452 at 1/20 dilution (0.5μg) immunoprecipitating Cytokeratin 8 in HeLa treated with Calyculin A whole cell lysate.
Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) treated with Calyculin A whole cell lysate 10μg
Lane 2 (+) : ab109452 + HeLa treated with Calyculin A whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab109452 in HeLa treated with Calyculin A whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 52 kDa
All lanes:
Immunoprecipitation - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (ab109452)
Predicted band size: 53 kDa
false
- WB
Unknown
Western blot - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (AB109452)
All lanes:
Western blot - Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] (ab109452) at 1/10000 dilution
Lane 1:
HeLa lysates, untreated at 10 µg
Lane 2:
HeLa lysates, treated with FBS and Calyculin A at 10 µg
Predicted band size: 53 kDa
Observed band size: 52 kDa
false
不同偶联物与剂型 (1)
-
Anti-Cytokeratin 8 (phospho S431) antibody [EP1630] - BSA and Azide free
反应性数据
产品详情
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (3)
Recent publications for all applications. Explore the full list and refine your search
Cellular and molecular life sciences : CMLS 79:95 PubMed35080691
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 26:297-308 PubMed33691026
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 126:4721-31 PubMed23902688
2013
Applications
Unspecified application
Species
Saccharomyces cerevisiae S288C
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com